This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an era of rapidly expanding use of transcatheter aorticvalve implantation (TAVI), the management of patients with bicuspidaorticvalve (BAV) disease is far less well established than in those with trileaflet anatomy.
Bicuspidaorticvalve (BAV), the most common congenital cardiac anomaly, predisposes individuals to aortic stenosis and regurgitation due to valve degeneration.
Background Bicuspidaorticvalve (BAV) is the most common congenital heart defect in adults, often leading to complications such as thoracic aortic aneurysms and aortic stenosis. While BAV is frequently associated with 22q11.2
Genetic variants linked to a rare form of bicuspidaorticvalve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.
ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aorticvalve system (Xcor system, Saint Medical Technology, Inc., of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.
Large and rare duplications and deletions in a chromosome region known as 22q11.2 , which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspidaorticvalve disease.
Transcript of the video: Closure line of aorticvalve on M-Mode echocardiogram, is seen as central line, while in bicuspidaorticvalve, it is an eccentric closure, nearer to one of the walls of the aorta. That is an important feature of bicuspidaorticvalve on M-Mode echocardiogram.
The co-occurrence of a bicuspidaorticvalve (BAV) with TSC is exceedingly rare.Case summaryWe report the case of a 26-year-old woman with genetically confirmed TSC, harboring a novel pathogenic variant in the TSC2 gene. multi-system characteristics of TSC were also presented, affecting skin, brain, lung, kidney, and bone.
1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspidaorticvalve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications. tim.hodson Wed, 09/04/2024 - 15:53 Sept.
Bicuspidaorticvalve (BAV) is a common congenital heart condition that can lead to some valve-related complications, such as aortic stenosis and/or regurgitation, and is often associated with aortic root dilation.
We investigated long-term outcomes, particularly later aorta operations and overall death in patients who underwent aorticvalve replacement for bicuspidaorticvalve without aortic surgery.
Quadricuspid aorticvalve (QAV) is rare. However, to repair a quadricuspid aorticvalve is not as easy to realize as in bicuspidaorticvalve. The surgical design is crucial to rebuild the stable structure.
The goal of the BICATOR trial was to determine whether treatment with low to moderate dose atorvastatin is associated with progression of ascending aortic dilation, valvular dysfunction, or valve calcification in patients with bicuspidaorticvalve.
This case report describes a 3-month-old male infant diagnosed with severe mitral stenosis (MS) and mitral regurgitation (MR) by transthoracic echocardiography. The male infant initially underwent complex mitralvalve repair surgery.
Objectives This study evaluates predictors of conduction abnormalities (CA) following transcatheter aorticvalve implantation (TAVI) in patients with bicuspidaorticvalves (BAV). Predictors of CA are well established among patients with tricuspid aorticvalves but not in those with BAV.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspidaortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2% 2.44];P=0.035).
(MedPage Today) -- Operators reported the initial success of a novel transcatheter technique for treating complex paravalvular leaks (PVLs) after transcatheter aorticvalve replacement (TAVR) or transcatheter mitralvalve replacement (TMVR) in.
Transthoracic echocardiography revealed severe aortic and mitral regurgitation, with a left ventricular ejection fraction of 37% and a left ventricular end-diastolic diameter of 64 mm. Despite receiving long-term optimal medical management, there was no improvement in symptoms or severity of valvular regurgitation.
What are the procedural and clinical outcomes of balloon-expandable valves (BEVs) and self-expanding valves (SEVs) in Sievers type 1 bicuspidaorticvalve (BAV) stenosis?
Douglas Weaver MD, MACC discuss the history of and complications associated with bicuspid valvuloaortopathy. In this interview, Hector I. Michelena, MD, FACC and W.
Here, we present a compelling case of windsock mitral va. Windsock deformities, though rare, represent a severe form of valvular aneurysm distinguished by localized balloon-like protrusions of the leaflet body.
Patients with bicuspidaorticvalves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aorticvalve replacement (TAVR) versus surgical aorticvalve replacement (SAVR) in patients with BAV.
BackgroundThe potential impact of exercise on valvular function and aortic diameters in patients with a bicuspidaorticvalve remains unclear. Vigorous intensity and exercise in mixed sports were associated with a lower prevalence of moderate‐to‐severe aortic stenosis.
Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aorticvalve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates.
BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aorticvalve replacement (SAVR) in patients with bicuspidaorticvalve (BAV) aortic stenosis (AS) versus patients with tricuspid aorticvalve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).
SAVR after TAVR Surgical aorticvalve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. More than 5,500 multi-valve procedures were performed in the U.S. in 2023, of which 60% included double valve replacements, and 25% involved concomitant CABG.
Pseudoaneurysm of the mitral-aortic intervalvular fibrosa (PMAIF) is a rare complication of infective endocarditis or aorticvalve surgery. Surgical treatment is suggested, but the long-term follow-up of conse.
BACKGROUND:A better understanding of the molecular mechanism of aorticvalve development and bicuspidaorticvalve (BAV) formation would significantly improve and optimize the therapeutic strategy for BAV treatment. Circulation, Ahead of Print.
Immediately after the procedure, significant systolic anterior motion and mitral regurgitation developed, necessitating a surgical mitral edge-to-edge repair. TA-BSM is a minimally invasive, safe, and effective surgical procedure for ameliorating LVOTO in patients with aorticvalve prostheses.
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aorticvalve replacement (TAVR) in 2002, as well as the first transcatheter mitral commissurotomy in 1995 and the first balloon aortic valvuloplasty in 1986. He passed away Feb.
Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aorticvalve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. after TAVR, were available from 247 patients (67.5%). ±15.8 ±15.1
In this scientific statement, we review the basic cellular structures of the human heart valves and discuss how these structures change in primary valvular heart disease.
(MedPage Today) -- PARIS -- Patients with questionable suitability for transcatheter aorticvalve replacement (TAVR) in fact fared worse in the short term after the catheter-based procedure than after surgery, the NOTION-2 randomized trial showed.
BACKGROUND:Patients with paradoxical low-flow, low-gradient severe aortic stenosis exhibit low transvalvular flow rate (Q), while maintaining preserved left ventricular ejection fraction. Severe mitral regurgitation (MR) also causes a low-flow state, adding complexity to diagnosis and management. P<0.001). P<0.001).
Publication date: Available online 30 April 2024 Source: The American Journal of Cardiology Author(s): Matthew S. Herzig, Susan McIlvaine, Loryn Feinberg, Melissa H. Spiel, Brett J.
In this view, you can see that mitral leaflets are thickened. This is anterior mitral leaflet, thickened, and in the closed position of mitralvalve, when there should be no flow to the left atrium, you are seeing a jet, a mosaic jet, which has been traced out. This is the mitral regurgitation jet.
TAVR and SAVR are procedures to replace a damaged aorticvalve that is not functioning properly. guidelines recommend TAVR, a catheter-based approach in which the new valve is threaded to the heart through a blood vessel in the groin or chest, over open-heart SAVR for older patients and those with high cardiovascular risk.
This technique is now employed in approximately 85% of all isolated aorticvalve replacements. In the past decade, the U.S. has seen a 25-fold increase in the use of TAVR, with more than 100,000 performed annually. Despite this growth, there are notable gaps in the evidence.
Here, this is the forward flow through the mitralvalve in diastole in red. This is reverse flow from the aorticvalve, that is aortic regurgitation jet. Area of the jet corresponding to the receiving chamber, that is left atrium, that is also deciding factor in assessing the severity of mitral regurgitation.
Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heart disease, including bicuspidaorticvalve, among others. The American Heart Association has published guidelines for diagnosis and management of thoracic aortic disease.
It uses a three-star scale (3=better than expected, 2=as expected, 1=worse than expected) to rate institutions across five common cardiovascular procedures: coronary artery bypass grafting (CABG); aorticvalve replacement (AVR); AVR and CABG; mitralvalve replacement/repair (MVRR); and MVRR and CABG.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content